|
![]() |
||
|
|
|
|
for Mental Health Research in 2006 273 scientists, in the United States and abroad, to use funds for innovative research on the causes and treatments of mental illnesses The grants should bring new insight to such illnesses as depression, bipolar disorder, schizophrenia, anxiety, autism, eating disorders, and other adult and childhood disorders. The funds support far-ranging research, covering subjects ranging from the genetics of schizophrenia to new treatments for depression. Now in its 20th year of grant making, NARSAD is the world’s largest donor-supported organization dedicated to funding innovative scientific research on psychiatric disorders. Previously known as the National Alliance for Research on Schizophrenia and Depression, NARSAD has helped expand the field of mental health research. Since 1987, it has distributed more than $199.3 million in grants to 2,948 research scientists in the United States and 25 other countries. This year’s grants, which attracted worldwide competition from a pool of more than 1,000 applicants, were awarded to 273 early-career, mid-career and established scientists to broaden and deepen the investigation of brain and behavior disorders. The funded scientists are based at universities and medical research institutions in the United States, Canada, Australia, Britain, Colombia, Costa Rica, Germany, Israel, Italy, Netherlands, South Korea and Switzerland. Click here to see a complete list of grant recipients and their institutions. “This group of scientists will extend the research potential for mental health,” said Constance E. Lieber, president of NARSAD. “Their work will continue to accelerate progress in the study of all areas of psychiatric disorders. They will take advantage of remarkable new technologies, powerful genetic insights and broadened experience to benefit the many millions of people suffering mental illnesses.” In the United States alone, approximately one in four people suffers a diagnosable mental disorder in any given year, with 6 percent, or 1 in 17, suffering a severe mental illness, according to the National Institute of Mental Health. NARSAD’s 2006 grantmaking includes:
“These scientists represent the best in the field and are pursuing the most innovative and promising research,” said Herbert Pardes, M.D., president and CEO of the NewYork-Presbyterian Hospital and Healthcare System, who is also president of NARSAD’s Scientific Council. The council, which reviews and recommends grants, comprises 94 pre-eminent neuroscientists, including Nobel Prize laureates Paul Greengard, Ph.D., Rockefeller University, and Eric Kandel, M.D., Columbia University. According to Dr. Pardes, some noteworthy trends in NARSAD’s 2006 grant projects include:
For additional information about the work of NARSAD, the research it supports and various psychiatric disorders, visit the organization’s Web site at www.narsad.org |
Media Contact
Upcoming NARSAD Events
Latest News from NARSAD
Spotlight
|
|